| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
Simmons Cancer Center [N. S. W., R. B. G., S. S., D. T.], and Departments of Medicine [R. B. G., U. V., E. F., C. B.], Pathology [T. G.], and Surgery [C. S., J. F.], University of Texas Southwestern Medical Center, Dallas, Texas 75390
Purpose: The purpose of this study was to profile gene expression changes in colorectal tumors to identify new targets and strategies for the management of this disease.
Experimental Design: cDNA microarray analysis was used to detect differences in gene expression between normal tissue and colon tumors and polyps isolated from 20 patients. To identify genes that are important in regulating the growth properties of colorectal cancer, RNA interference (RNAi) was used to disrupt expression of several of the overexpressed genes in a colon tumor cell line, HCT116, which showed similar patterns of gene expression as many of the patient tumors.
Results: Expression changes of 
2-fold in approximately one-third of the patients were consistently observed for 2632 of a total of 9592 genes (574 up-regulated genes and 2058 down-regulated genes). Subsequent analysis of 13 genes by quantitative real-time PCR confirmed the reliability of this analysis. RNAi-mediated disruption of the expression of one of these genes, survivin, a potent inhibitor of apoptosis, severely reduced tumor growth both in vitro and in an in vivo xenograft model.
Conclusions: The combined use of microarray analysis and RNAi provides an excellent system to define the role of specific genes that are up-regulated in cancer lead to the increased in vitro and in vivo growth of colon tumors.
This article has been cited by other articles:
|
|
 |
|
  K. Motoyama, F. Tanaka, Y. Kosaka, K. Mimori, H. Uetake, H. Inoue, K. Sugihara, and M. Mori Clinical Significance of BMP7 in Human Colorectal Cancer Ann. Surg. Oncol., May 1, 2008; 15(5): 1530 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Chen, W. M. Ehrhardt, R. B. Halberg, B. J. Aronow, and W. F. Dove Cellular Expression Patterns of Genes Upregulated in Murine and Human Colonic Neoplasms J. Histochem. Cytochem., May 1, 2008; 56(5): 433 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Chan, O. L. Griffith, I. T. Tai, and S. J.M. Jones Meta-analysis of Colorectal Cancer Gene Expression Profiling Studies Identifies Consistently Reported Candidate Biomarkers Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 543 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Madoz-Gurpide, M. Canamero, L. Sanchez, J. Solano, P. Alfonso, and J. I. Casal A Proteomics Analysis of Cell Signaling Alterations in Colorectal Cancer Mol. Cell. Proteomics, December 1, 2007; 6(12): 2150 - 2164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Z. J. Chu, G. Gibson, D. David, and Y. Yen The Surgeon's Role in Cancer Prevention. The Model in Colorectal Carcinoma Ann. Surg. Oncol., November 1, 2007; 14(11): 3054 - 3069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Krambeck, H. Dong, R. H. Thompson, S. M. Kuntz, C. M. Lohse, B. C. Leibovich, M. L. Blute, T. J. Sebo, J. C. Cheville, A. S. Parker, et al. Survivin and B7-H1 Are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal Cell Carcinoma Clin. Cancer Res., March 15, 2007; 13(6): 1749 - 1756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.-O. Esteve, H. G. Chin, and S. Pradhan Molecular Mechanisms of Transactivation and Doxorubicin-mediated Repression of survivin Gene in Cancer Cells J. Biol. Chem., January 26, 2007; 282(4): 2615 - 2625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Madoz-Gurpide, P. Lopez-Serra, J. L. Martinez-Torrecuadrada, L. Sanchez, L. Lombardia, and J. I. Casal Proteomics-based Validation of Genomic Data: Applications in Colorectal Cancer Diagnosis Mol. Cell. Proteomics, August 1, 2006; 5(8): 1471 - 1483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nakamura, S. Suzuki, T. Suzuki, K. Ono, I. Miura, F. Satoh, T. Moriya, H. Saito, S. Yamada, S. Ito, et al. MDM2: A Novel Mineralocorticoid-Responsive Gene Involved in Aldosterone-Induced Human Vascular Structural Remodeling Am. J. Pathol., August 1, 2006; 169(2): 362 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Mizukami, K. Fujiki, E.-M. Duerr, M. Gala, W.-S. Jo, X. Zhang, and D. C. Chung Hypoxic Regulation of Vascular Endothelial Growth Factor through the Induction of Phosphatidylinositol 3-Kinase/Rho/ROCK and c-Myc J. Biol. Chem., May 19, 2006; 281(20): 13957 - 13963. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Rodel, J. Hoffmann, L. Distel, M. Herrmann, T. Noisternig, T. Papadopoulos, R. Sauer, and C. Rodel Survivin as a Radioresistance Factor, and Prognostic and Therapeutic Target for Radiotherapy in Rectal Cancer Cancer Res., June 1, 2005; 65(11): 4881 - 4887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-i. Maruya, H.-W. Kim, R. S. Weber, J. J. Lee, M. Kies, M. A. Luna, J. G. Batsakis, and A. K. El-Naggar Gene Expression Screening of Salivary Gland Neoplasms: Molecular Markers of Potential Histogenetic and Clinical Significance J. Mol. Diagn., August 1, 2004; 6(3): 180 - 190. [Abstract] [Full Text]
|
|
|
|
|
|
L.-C. Chen, C.-Y. Hao, Y. S. Y. Chiu, P. Wong, J. S. Melnick, M. Brotman, J. Moretto, F. Mendes, A. P. Smith, J. L. Bennington, et al. Alteration of Gene Expression in Normal-Appearing Colon Mucosa of APCmin Mice and Human Cancer Patients Cancer Res., May 15, 2004; 64(10): 3694 - 3700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Guo, U. N. Verma, R. B. Gaynor, E. P. Frenkel, and C. R. Becerra Enhanced Chemosensitivity to Irinotecan by RNA Interference-Mediated Down-Regulation of the Nuclear Factor-{kappa}B p65 Subunit Clin. Cancer Res., May 15, 2004; 10(10): 3333 - 3341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. OCHS, T. D. MOLOSHOK, G. BIDAUT, and G. TOBY Bayesian Decomposition: Analyzing Microarray Data within a Biological Context Ann. N.Y. Acad. Sci., May 1, 2004; 1020(1): 212 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Beltrami, J. Plescia, J. C. Wilkinson, C. S. Duckett, and D. C. Altieri Acute Ablation of Survivin Uncovers p53-dependent Mitotic Checkpoint Functions and Control of Mitochondrial Apoptosis J. Biol. Chem., January 16, 2004; 279(3): 2077 - 2084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Pisarev, B. Yu, R. Salup, S. Sherman, D. C. Altieri, and D. I. Gabrilovich Full-Length Dominant-Negative Survivin for Cancer Immunotherapy Clin. Cancer Res., December 15, 2003; 9(17): 6523 - 6533. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
